aluminum phosphide has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, M; Kumar P, P; Nair, P; Raveendran, M; Ravi, SV; Sivakumar, K | 1 |
| Alpert, MA; Ingole, A; Jadhav, AP; Nusair, MB | 1 |
| Sanaei-Zadeh, H | 1 |
| Cobos, MA; Dueñas, A; Herreros, V; Pérez-Castrillon, JL | 1 |
4 other study(ies) available for aluminum phosphide and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
A Rare Survival in Celphos Poisoning.
Topics: Aluminum Compounds; Arrhythmias, Cardiac; Humans; Phosphines; Poisoning; Tachycardia, Ventricular | 2018 |
Unresponsive ventricular tachycardia associated with aluminum phosphide poisoning.
Topics: Aluminum Compounds; Electrocardiography; Emergency Service, Hospital; Fatal Outcome; Heart; Humans; Male; Myocardium; Phosphines; Suicide; Tachycardia, Ventricular; Young Adult | 2012 |
Regarding "unresponsive ventricular tachycardia associated with aluminum phosphide poisoning".
Topics: Aluminum Compounds; Humans; Phosphines; Tachycardia, Ventricular | 2012 |
Treatment of the cardiovascular manifestations of phosphine poisoning with trimetazidine, a new antiischemic drug.
Topics: Administration, Inhalation; Adult; Aluminum Compounds; Electrocardiography; Emergencies; Humans; Male; Occupational Diseases; Phosphines; Poisoning; Tachycardia, Ventricular; Trimetazidine; Vasodilator Agents | 1999 |